HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients-Reference-Cited by-同舟云学术

HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients

Published:2017-10-11 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Guo Wenting,Naujock Maximilian,Fumagalli Laura,Vandoorne Tijs,Baatsen Pieter,Boon Ruben,Ordovás Laura^ORCID,Patel Abdulsamie,Welters Marc,Vanwelden Thomas,Geens Natasja,Tricot Tine,Benoy Veronick,Steyaert Jolien,Lefebvre-Omar Cynthia,Boesmans Werend^ORCID,Jarpe Matthew,Sterneckert Jared,Wegner Florian,Petri Susanne,Bohl Delphine,Vanden Berghe Pieter^ORCID,Robberecht Wim,Van Damme Philip^ORCID,Verfaillie Catherine^ORCID,Van Den Bosch Ludo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-00911-y.pdf

Reference55 articles.

1. Renton, A. E., Chiò, A. & Traynor, B. J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17–23 (2014).

2. Bensimon, G., Lacomblez, L. & Meininger, V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med. 330, 585–591 (1994).

3. Poppe, L., Rué, L., Robberecht, W. & Van Den Bosch, L. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS). Exp. Neurol. 262, 138–151 (2014).

4. Arbab, M., Baars, S. & Geijsen, N. Modeling motor neuron disease: the matter of time. Trends Neurosci. 37, 642–652 (2014).

5. Lanson, N. A. & Pandey, U. B. FUS-related proteinopathies: lessons from animal models. Brain Res. 1462, 44–60 (2012).

Cited by 290 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of DNA damage response by RNA/DNA-binding proteins: Implications for neurological disorders and aging;Ageing Research Reviews;2024-09

2. ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes;Nature Communications;2024-08-29

3. Axonopathy Underlying Amyotrophic Lateral Sclerosis: Unraveling Complex Pathways and Therapeutic Insights;Neuroscience Bulletin;2024-08-04

4. Genetic link between KIF1A mutations and amyotrophic lateral sclerosis: evidence from whole-exome sequencing;Frontiers in Aging Neuroscience;2024-07-15

5. HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS;Heliyon;2024-07